Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;50:1142-1147
Published online before print October 8, 2007, doi: 10.1161/HYPERTENSIONAHA.107.096594
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
50/6/1142    most recent
HYPERTENSIONAHA.107.096594v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gilbert, J. S.
Right arrow Articles by Granger, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilbert, J. S.
Right arrow Articles by Granger, J. P.
Related Collections
Right arrow Animal models of human disease
Right arrow Other hypertension
Right arrow Hypertension - basic studies

(Hypertension. 2007;50:1142.)
© 2007 American Heart Association, Inc.


Original Articles

Hypertension Produced by Reduced Uterine Perfusion in Pregnant Rats Is Associated With Increased Soluble Fms-Like Tyrosine Kinase-1 Expression

Jeffrey S. Gilbert; Sara A. Babcock; Joey P. Granger

From the Department of Physiology and the Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, Jackson, Miss.

Correspondence to Joey P. Granger, Department of Physiology and Biophysics, University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216-4505. E-mail jgranger{at}physiology.umsmed.edu

The balance between proangiogenic and antiangiogenic factors, such as vascular endothelial growth factor, placental growth factor, and soluble fms-like tyrosine kinase-1 (sFlt-1), is altered in preeclampsia, and this dysregulation of angiogenic factors may be important in the pathogenesis of preeclampsia. Although sFlt-1 is elevated in preeclampsia, the mechanisms responsible for increasing this antiangiogenic factor remain unclear. We hypothesized that the hypertension produced by reduced uterine perfusion pressure (RUPP) is associated with increased sFlt-1 expression and decreased plasma vascular endothelial growth factor and placental growth factor concentrations in the pregnant rat. Arterial pressure was increased (130±3 versus 100±2 mm Hg; P<0.01) in the RUPP rats compared with the normal pregnant control rats. Plasma sFlt-1 concentration (660±270 versus 82±26 pg/mL; P<0.05) was increased, whereas plasma free placental growth factor (0.28±0.05 versus 1.7±0.5 pg/mL; P<0.01) and vascular endothelial growth factor (594±34 versus 830±33 pg/mL; P<0.01) concentrations were decreased in the RUPP rats compared with normal pregnant rats. Plasma sFlt-1:placental growth factor (37.2±7.8 versus 8.9±1.6; P<0.02) and sFlt-1:vascular endothelial growth factor (0.86±0.22 versus 0.28±0.06; P<0.05) ratios were increased in the RUPP rats compared with normal pregnant rats. Immunoreactive placental sFlt-1 was increased (1.1±0.1 versus 0.3±0.1; P<0.01) in RUPP rats contrasted with the normal pregnant rats. These findings support our hypothesis that RUPP increases the expression of sFlt-1 and alters the balance of angiogenic factors in the maternal circulation. These data also indicate that the RUPP model of pregnancy-induced hypertension may provide an invaluable model for mechanistic studies into the role of sFlt-1 in the pathogenesis preeclampsia.


Key Words: preeclampsia • gestation • VEGF • blood pressure • angiogenic




This article has been cited by other articles:


Home page
HypertensionHome page
B. D. LaMarca, J. Gilbert, and J. P. Granger
Recent Progress Toward the Understanding of the Pathophysiology of Hypertension During Preeclampsia
Hypertension, April 1, 2008; 51(4): 982 - 988.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Osol, G. Celia, N. Gokina, C. Barron, E. Chien, M. Mandala, L. Luksha, and K. Kublickiene
Placental growth factor is a potent vasodilator of rat and human resistance arteries
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1381 - H1387.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. S. Gilbert, M. J. Ryan, B. B. LaMarca, M. Sedeek, S. R. Murphy, and J. P. Granger
Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H541 - H550.
[Abstract] [Full Text] [PDF]